CNS Specific Antisense Oligonucleotides Market
CNS Specific Antisense Oligonucleotides Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
CNS Specific Antisense Oligonucleotides Market Size and Growth
The CNS-specific antisense oligonucleotides market is poised for significant growth, driven by advancements in therapeutic applications and increasing investments in neurological research. The market size is projected to reach approximately $2.5 billion by 2027, reflecting a compound annual growth rate (CAGR) of over 15%, driven by rising demand for targeted therapies.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Akcea Therapeutics, Inc.
◍ Ionis Pharmaceuticals Inc.
◍ Biogen Inc.
◍ Sarepta Therapeutics
◍ Wave Life Sciences Ltd.
◍ Dynacure
◍ ProQR Therapeutics N.V.
◍ Stroke Therapeutic Inc.
The CNS-specific antisense oligonucleotides market includes key players like Akcea Therapeutics, Ionis Pharmaceuticals, Biogen, Sarepta Therapeutics, Wave Life Sciences, Dynacure, ProQR Therapeutics, and Stroke Therapeutics. These companies drive market growth through innovative therapies targeting neurological disorders. Sales revenue figures include Ionis Pharmaceuticals: approximately $800 million.
Request Sample Report
Market Segmentation
By Application
◍ Hospital Pharmacies
◍ Retail Pharmacies
◍ Online Pharmacies
By Product
◍ Polyneuropathy Treatment
◍ Spinal Muscular Atrophy (SMA) Treatment
◍ Huntington’s Disease Treatment
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
